Though there are currently few approved treatments for advanced, pre-treated small cell lung cancer (SCLC), this patient population may have a safe and effective new option in apatinib, according to updated data from a prospective phase 2 study.
IASLC World Conference on Lung Cancer
Advertisement
In a survey conducted by the Cancer Support Community, 33% of patients with lung cancer reported they were somewhat or not at all involved in the decision-making process, and 66% were not as knowledgeable about their treatment options as needed to make this decision.
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Could a Genomic Test Spare You Extra Years of Hormone Therapy?
2
My Sister and I Share a BRCA2 Mutation. We Didn’t Make the Same Choices
3
I’m Jealous of the World — and Grateful I Got to Be Part of It
4
We Eat Bagels Before Cancer Treatment. Here’s Why.
5